zonisamide has been researched along with Protein-Losing Enteropathies in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of protein-losing cytomegalovirus gastritis in a previously immunocompetent 14-year-old Japanese girl that occurred during treatment of drug (zonisamide)-induced Stevens-Johnson syndrome with hepatic failure." | 3.71 | Protein-losing cytomegalovirus gastritis in a patient with Stevens-Johnson syndrome. ( Ishiguro, N; Itoh, T; Kikuta, H; Kobayashi, K; Kodaira, J; Ma, X; Yoshioka, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshioka, M | 1 |
| Ishiguro, N | 1 |
| Ma, X | 1 |
| Kikuta, H | 1 |
| Kodaira, J | 1 |
| Itoh, T | 1 |
| Kobayashi, K | 1 |
1 other study available for zonisamide and Protein-Losing Enteropathies
| Article | Year |
|---|---|
Protein-losing cytomegalovirus gastritis in a patient with Stevens-Johnson syndrome.
Topics: Adolescent; Anticonvulsants; Cytomegalovirus Infections; Female; Gastritis; Gastroscopy; Humans; Imm | 2002 |